NEO
$16.58
Revenue | $167.82Mn |
Net Profits | $-17.7Mn |
Net Profit Margins | -10.55% |
Neogenomics, Inc.’s revenue jumped 10.44% since last year same period to $167.82Mn in the Q3 2024. On a quarterly growth basis, Neogenomics, Inc. has generated 2.02% jump in its revenue since last 3-months.
Neogenomics, Inc.’s net profit jumped 4.41% since last year same period to $-17.7Mn in the Q3 2024. On a quarterly growth basis, Neogenomics, Inc. has generated 5.06% jump in its net profits since last 3-months.
Neogenomics, Inc.’s net profit margin jumped 13.45% since last year same period to -10.55% in the Q3 2024. On a quarterly growth basis, Neogenomics, Inc. has generated 6.94% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.01 |
EPS Estimate Current Year | 0.01 |
Neogenomics, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.01 - a 534.78% jump from last quarter’s estimates.
Neogenomics, Inc.’s earning per share (EPS) estimates for the current year stand at 0.01.
Earning Per Share (EPS) | -0.14 |
Neogenomics, Inc.’s earning per share (EPS) jumped 5.36% since last year same period to -0.14 in the Q3 2024. This indicates that the Neogenomics, Inc. has generated 5.36% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-30 | -0.05 | -0.02 | 60% |
2024-07-30 | -0 | 0.03 | 1404.35% |
2024-11-05 | 0.01 | -0.14 | -1494% |